Compared side by side

TB-500 vs Ac-SDKP: how they differ

Reviewed How we check the libraryPublished by PepVault

The short answer

Both come from thymosin beta-4, from different ends: TB-500 is residues 17–23, the stretch that binds actin, and Ac-SDKP is residues 1–4, sold as a “TB-500 fragment” though it isn’t part of TB-500. In rodent studies Ac-SDKP calms inflammation and scarring in the heart, kidneys and lungs and helps new blood vessels form, while TB-500 sped wound repair in aged mice and strengthened repaired tendons in rats. Ac-SDKP is cleared by ACE within minutes, and no study has looked at it for tendons or ligaments.

Side by side

ComparedTB-500Ac-SDKP
CategoryHealing & recoveryHealing & recovery
Also known asThymosin Beta-4 Fragment, TB4TB-500 Fragment, TB-4 Frag, Goralatide, Thymosin Beta-4 (1-4)
What it isA fragment of thymosin beta-4, a protein your body uses for cell repair.The first four amino acids of thymosin beta-4, sold as a 'TB-500 fragment' though it isn't part of TB-500.
How it worksSynthetic fragment of Thymosin Beta-4: Ac-LKKTETQ, the 7-amino-acid stretch (residues 17–23) that binds actin. The whole protein holds actin building blocks back from forming filaments, a reserve cells draw on when they move. In lab and rodent studies the fragment drew blood-vessel cells, sped wound repair in aged mice and strengthened repaired tendons in rats; the anti-inflammatory findings are for the whole protein. Loading phase 2x/week then drop to maintenance.Isolated N-terminal tetrapeptide of Thymosin Beta-4, residues 1–4; TB-500 itself is residues 17–23, so this isn't part of TB-500. In rodent and cell studies it is anti-inflammatory and anti-fibrotic in heart, kidney and lung models and promotes angiogenesis and cell migration. It is cleared by ACE within minutes, and ACE inhibitors raise its blood levels about fourfold.
Commonly reportedStubborn soft-tissue injuries loosening up, with range of motion returning over a few weeks. Its own research is a few animal studies; the human trials tested the whole protein. Often paired with BPC-157.Community data are sparse, and users who report on it describe it much like TB-500, a gradual easing of soft-tissue aches.
Studied rangeResearch range: 1–2.5 mg. Studied in research — not a recommendation.Research range: 250–750 mcg. Studied in research — not a recommendation.
How often2x/week loading, 1–2mg/week maintenanceEOD or twice weekly.
Half-life~0.5–2 hours (measured for the whole protein, thymosin beta-4, given IV to healthy volunteers; TB-500 itself has never been measured in people)~4.5 min (measured in healthy volunteers after IV; cleared by ACE, and a SubQ dose peaks in about 15 minutes)
RouteSubQ injection, IM injectionSubQ injection
Typical runLoading phase 2x/week for 4–6 weeks, then maintenance 1x/week or stop. Common to cycle 6–8 weeks on, time off.6-8 week cycles typical. Preferred over full TB-500 by some for targeted tendon/ligament work.
EvidenceEmerging: primarily preclinical / limited human dataEmerging: primarily preclinical / limited human data
Common side effectsInjection site reaction, fatigue, nausea, headache, lethargyInjection site reaction, fatigue, headache

Typical run: Community practice — opinions vary. Not a clinical recommendation.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Taking TB-500 or Ac-SDKP? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

TB-500

  • Day 1–7 Week one: set your baseline
  • Day 7–14 Stiffness often starts to ease
  • Day 14–28 Load tolerance often picks up
  • Day 28–42 Gains slow, repair keeps going
  • Day 42–56 Weeks 6 to 8: how far it's come

Every card for TB-500, with its sources

Ac-SDKP

Week-by-week cards for Ac-SDKP are not in our library.

Every card for Ac-SDKP, with its sources

Together or one or the other

TB-500 and Ac-SDKP are a common stack: Ac-SDKP lists TB-500 among its common stacks.

Questions people ask

How long do TB-500 and Ac-SDKP last?

The half-life of TB-500 is ~0.5–2 hours (measured for the whole protein, thymosin beta-4, given IV to healthy volunteers; TB-500 itself has never been measured in people). The half-life of Ac-SDKP is ~4.5 min (measured in healthy volunteers after IV; cleared by ACE, and a SubQ dose peaks in about 15 minutes).

How often are TB-500 and Ac-SDKP taken?

TB-500: 2x/week loading, 1–2mg/week maintenance. Routes: SubQ injection, IM injection. Ac-SDKP: EOD or twice weekly. Route: SubQ injection.

How are TB-500 and Ac-SDKP dosed in research?

The research range for TB-500 is 1–2.5 mg. The research range for Ac-SDKP is 250–750 mcg. Studied in research — not a recommendation.

What are the common side effects of TB-500 and Ac-SDKP?

For TB-500, the library lists: injection site reaction, fatigue, nausea, headache, lethargy. For Ac-SDKP: injection site reaction, fatigue, headache.

Are TB-500 and Ac-SDKP taken together?

TB-500 and Ac-SDKP are a common stack: Ac-SDKP lists TB-500 among its common stacks.

Each one in full

Track it in the app

PepVault for iPhone

Taking TB-500 or Ac-SDKP? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo